Search Results - "Psatha, Nikoleta"
-
1
526. Specific Companion Cells Enhance the Engraftment of Ex-Vivo Expanded HSCs (CD34+/CD38−/CD90+)
Published in Molecular therapy (01-05-2016)Get full text
Journal Article -
2
Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming
Published in Cancers (23-03-2023)“…T-cell-based, personalized immunotherapy can nowadays be considered the mainstream treatment for certain blood cancers, with a high potential for expanding…”
Get full text
Journal Article -
3
Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy
Published in Cancers (01-12-2023)“…Regulatory T cells (Tregs) are fundamental to maintaining immune homeostasis by inhibiting immune responses to self-antigens and preventing the excessive…”
Get full text
Journal Article -
4
Single-cell spatial multi-omics and deep learning dissect enhancer-driven gene regulatory networks in liver zonation
Published in Nature cell biology (01-01-2024)“…In the mammalian liver, hepatocytes exhibit diverse metabolic and functional profiles based on their location within the liver lobule. However, it is unclear…”
Get full text
Journal Article -
5
Introduction of Two Simultaneous Mutations By Genome Editing Greatly Enhances the Accumulation of the Endogenous Fetal Hemoglobin in Human Normal Erythroid Cells
Published in Blood (08-12-2017)“…Thalassemia or sickle cell patients with increased fetal hemoglobin have an ameliorated clinical picture up to transfusion independency. Genome editing with…”
Get full text
Journal Article -
6
The diverse genetic origins of a Classical period Greek army
Published in Proceedings of the National Academy of Sciences - PNAS (11-10-2022)“…Trade and colonization caused an unprecedented increase in Mediterranean human mobility in the first millennium BCE. Often seen as a dividing force, warfare is…”
Get full text
Journal Article -
7
Thalassemia Gene Therapy By In Vivo Transduction of Mobilized Hematopoietic Stem Cells (HSCs) with an Integrating Hybrid Adenovirus Vector System
Published in Blood (29-11-2018)“…To overcome the cost and complexity of current thalassemia ex vivogene therapy protocols, we developed a minimally invasive and readily translatable approach…”
Get full text
Journal Article -
8
In Vivo HSC Transduction and Selection Results in Long-Term, High-Level Expression of Human Gamma Globin in Peripheral Blood Erythrocytes of Mice
Published in Blood (08-12-2017)“…Current protocols for HSC gene therapy, involving the transplantation of ex vivo lentivirus vector-transduced HSCs into myeloablated recipients, are complex…”
Get full text
Journal Article -
9
Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects
Published in Molecular therapy (01-01-2012)“…The safety and efficacy of hematopoietic stem cell (HSC) mobilization was investigated in adult splenectomized (SPL) and non-SPL patients with thalassemia…”
Get full text
Journal Article -
10
Plerixafor+G-CSF-Mobilized Blood From Thalassemic Mice Provides High Yields Of Long-Term Repopulating Cells With Enhanced Engrafting Capacity : Implications For Human Stem Cell Gene Therapy
Published in Blood (15-11-2013)“…A durable therapeutic effect of gene therapy in β-thalassemia largely depends on the infusion of high numbers of genetically-modified hematopoietic stem cells…”
Get full text
Journal Article -
11
Superior long-term repopulating capacity of G-CSF+plerixafor-mobilized blood: implications for stem cell gene therapy by studies in the Hbb(th-3) mouse model
Published in Human gene therapy. Part B. Methods (01-12-2014)“…High numbers of genetically modified hematopoietic stem cells (HSCs) equipped with enhanced engrafting potential are required for successful stem cell gene…”
Get more information
Journal Article -
12
Hematopoietic Cell Mobilization for Gene Therapy of Adult Patients with Severe Beta-Thalassemia: The Challenge of Splenectomy and the Role of Plerixafor
Published in Blood (18-11-2011)“…Abstract 166▪FN2▪This icon denotes a clinically relevant abstract In preparation for a trial for gene therapy of thalassemia, we investigated the safety and…”
Get full text
Journal Article -
13
The Combination of AMD3100 + G-CSF Restores the Ineffective Hematopoietic Stem Cell Mobilization with G-CSF Alone in a Thalassemic Mouse Model
Published in Blood (20-11-2009)“…Abstract 3234 Poster Board III-171 Gene therapy has been recently postulated as a realistic therapeutic potential for thalassemia and the mobilized autologous…”
Get full text
Journal Article -
14
Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe [beta]-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects
Published in Molecular therapy (01-01-2012)“…The safety and efficacy of hematopoietic stem cell (HSC) mobilization was investigated in adult splenectomized (SPL) and non-SPL patients with thalassemia…”
Get full text
Journal Article -
15
Mobilization of hematopoietic stem cells in a thalassemic mouse model: implications for human gene therapy of thalassemia
Published in Human gene therapy (01-03-2010)“…Granulocyte colony-stimulating factor (G-CSF)-mobilized blood stem cells may become the preferable source of hematopoietic stem cells (HSCs) for gene therapy…”
Get more information
Journal Article